These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6739150)

  • 1. [In vitro sensitivity of strict anaerobic Gram-negative bacilli to thienamycin NF and various cephalosporins].
    Dubreuil L; Devos J; Romond C
    Pathol Biol (Paris); 1984 May; 32(5):429-32. PubMed ID: 6739150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative antibacterial activity of cefpodoxime, cefuroxime and cefaclor against strict anaerobic bacteria].
    Dubreuil L; Derriennic M; Sedallian A
    Pathol Biol (Paris); 1990 May; 38(5):343-6. PubMed ID: 2367150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of imipenem against gram-positive anaerobic bacteria.
    Dubreuil L; Devos J; Romond C
    Int J Clin Pharmacol Res; 1987; 7(1):39-43. PubMed ID: 3473047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.
    Brown JE; Del Bene VE; Collins CD
    Antimicrob Agents Chemother; 1981 Feb; 19(2):248-52. PubMed ID: 6214986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro activities of third-generation cephalosporins.
    Fass RJ
    Arch Intern Med; 1983 Sep; 143(9):1743-5. PubMed ID: 6615095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on the in vitro activity of ceftizoxime and other cephalosporin/cephamycin antimicrobial agents against clinically significant anaerobic bacteria.
    Aldridge KE
    Clin Ther; 1990; 12 Suppl C():3-12. PubMed ID: 2202509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro activity of the oxa-beta-lactam LY 127935 against Bacteroides fragilis and other anaerobic gram-negative rods (author's transl)].
    Werner H; Krasemann C
    Infection; 1980; 8 Suppl 3():S 342-6. PubMed ID: 6447673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ["In vitro" activity of ten antimicrobial agents against anaerobic bacteria. A collaborative study, 1999-2002].
    Litterio M; Bianchini H; Carloni G; Di Martino A; Fernández Canigia L; Greco G; Legaria C; Rollet R; Rossetti A; Predari SC; Castello L
    Rev Argent Microbiol; 2004; 36(3):130-5. PubMed ID: 15559195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece.
    Papaparaskevas J; Pantazatou A; Katsandri A; Legakis NJ; Avlamis A;
    Clin Microbiol Infect; 2005 Oct; 11(10):820-4. PubMed ID: 16153256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of tigecycline against recently isolated Gram-negative anaerobic bacteria in Greece, including metronidazole-resistant strains.
    Katsandri A; Avlamis A; Pantazatou A; Petrikkos GL; Legakis NJ; Papaparaskevas J;
    Diagn Microbiol Infect Dis; 2006 Jul; 55(3):231-6. PubMed ID: 16626904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of imipenem and six other beta-lactam antibiotics against aminoglycoside resistant gram-negative bacilli.
    Bujdáková H; Kallová J; Lausová A; Kettner M
    Microbios; 1995; 84(339):87-90. PubMed ID: 8628124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin.
    Owens WE; Finegold SM
    Antimicrob Agents Chemother; 1983 Apr; 23(4):626-9. PubMed ID: 6305265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of cefbuperazone compared with that of other new beta-lactam agents against anaerobic gram-negative bacilli and contribution of beta-lactamase to resistance.
    Del Bene VE; Carek PJ; Twitty JA; Burkey LJ
    Antimicrob Agents Chemother; 1985 May; 27(5):817-20. PubMed ID: 3874597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of thienamycin.
    Shah PM
    Methods Find Exp Clin Pharmacol; 1981; 3(6):387-90. PubMed ID: 7329164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of anaerobic bacteria to cefoperazone and other beta-lactam antibiotics.
    Jacobus NV; Tally FP; Barza M; Gorbach SL
    Clin Ther; 1980; 3(Spec Issue):34-8. PubMed ID: 6446396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteria.
    DeMaria A; Alvarez S; Klein JO; McCabe WR
    Infection; 1980; 8 Suppl 3():S 261-7. PubMed ID: 6447671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibilities of common gram negative bacilli to aminoglycosides and cephalosporins.
    Patamasucon P; Kalnauwakul S; Ratamaruesa A; Silpapojakul K
    J Med Assoc Thai; 1987 Sep; 70(9):511-5. PubMed ID: 3681179
    [No Abstract]   [Full Text] [Related]  

  • 18. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
    Corser CA; Day GJ; Humble MW
    N Z Med J; 1982 Jun; 95(710):414-6. PubMed ID: 6810246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative antimicrobial activity of aminothiazolyl methoxyimino cephalosporins against anaerobic bacteria, including 100 cefoxitin-resistant isolates.
    Jones RN; Barry AL; Aldridge KE; Gerlach EH
    Diagn Microbiol Infect Dis; 1987 Nov; 8(3):157-63. PubMed ID: 3501976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristic of clinical strains of gram-negative obligate anaerobes].
    Kadzielska J; Kierzkowska M; Sawicka-Grzelak A; Rokosz A; Łuczak M
    Med Dosw Mikrobiol; 2007; 59(4):351-7. PubMed ID: 18416127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.